Cargando…
Genome-Scale Metabolic Model of the Human Pathogen Candida albicans: A Promising Platform for Drug Target Prediction
Candida albicans is one of the most impactful fungal pathogens and the most common cause of invasive candidiasis, which is associated with very high mortality rates. With the rise in the frequency of multidrug-resistant clinical isolates, the identification of new drug targets and new drugs is cruci...
Autores principales: | Viana, Romeu, Dias, Oscar, Lagoa, Davide, Galocha, Mónica, Rocha, Isabel, Teixeira, Miguel Cacho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7559133/ https://www.ncbi.nlm.nih.gov/pubmed/32932905 http://dx.doi.org/10.3390/jof6030171 |
Ejemplares similares
-
Microevolution of the pathogenic yeasts Candida albicans and Candida glabrata during antifungal therapy and host infection
por: Pais, Pedro, et al.
Publicado: (2019) -
A Genome-Scale Metabolic Model for the Human Pathogen Candida Parapsilosis and Early Identification of Putative Novel Antifungal Drug Targets
por: Viana, Romeu, et al.
Publicado: (2022) -
Divergent Approaches to Virulence in C. albicans and C. glabrata: Two Sides of the Same Coin
por: Galocha, Mónica, et al.
Publicado: (2019) -
Carrier-Mediated Drug Uptake in Fungal Pathogens
por: Galocha, Mónica, et al.
Publicado: (2020) -
Draft Genome Sequences of Three Clinical Isolates of the Pathogenic Yeast Candida glabrata
por: Pais, Pedro, et al.
Publicado: (2019)